Medifast (MED) Misses Q4 EPS by 2c, Offers Q1 & FY Guidance

Medifast (NYSE: MED) reported Q4 EPS of $0.33, $0.02 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $61.3 million versus the consensus estimate of $62.98 million.

GUIDANCE:

Medifast sees Q1 2016 EPS of $0.30-$0.33, versus the consensus of $0.44. Medifast sees Q1 2016 revenue of $68-71 million, versus the consensus of $72.98 million.

• For fiscal year 2016, the Company expects revenue from continuing operations to be in the range of $273.0 million to $280.0 million and earnings per diluted share from continuing operations in the range of $1.73 to $1.78 per diluted share

(Streets sees FY16 EPS of $1.85 on revenue of $282.08 million)

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Equity Residential (EQR) Tops Q1 EPS by 44c; offers guidance
• Veralto Corporation (VLTO) Tops Q1 EPS by 6c, Offers Guidance